Recruiting NA Mild Cognitive Impairment

New treatment option for Mild Cognitive Impairment

Official title Comparison of the Effects of Bimanual, Finger and VR Exercises in PwMCI

ClinicalTrials.gov ID: NCT06935812

What this study is testing

What it's testing
Mild Cognitive Impairment (MCI) is defined as an impairment in a single cognitive function, usually memory, other than normal cognitive decline with age, that does not fulfil dementia criteria. Finger movements have been shown to stimulate the sensory-motor and cognitive parts of the cerebral cortex, as well as the supplementary motor area, Broca's area, premotor cortex, and prefrontal cortex, all of which contribute to movement skills.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 50 to 75. Healthy volunteers may be eligible.

You may be able to join if

  • Participants who are between 50-75 years of age
  • Individuals diagnosed with MCI by a geriatrician according to DSM-5 criteria,
  • Who has the Montreal Cognitive Assessment score between 13-26,
  • Who has the Quick Mild Cognitive Impairment screen score between 48-67,
  • Who has Instrumental Activities of Daily Living Scale score ≥6/8,

You likely can't join if

  • Participants who have any musculoskeletal disorders that may cause balance and gait disorders,
  • Who have central or peripheral neurological diseases (eg. stroke, Parkinson's disease or polyneuropathies),
  • Who are using psychiatric drugs that may affect psychiatric disease and/or cognitive performance (Using nonsteroidal anti-inflammatory drugs more...
  • Who has daltonism and
  • Who attends any exercise program last 6 months will not be included in this study.
See the full eligibility criteria
Who can join
  • Participants who are between 50-75 years of age
  • Individuals diagnosed with MCI by a geriatrician according to DSM-5 criteria,
  • Who has the Montreal Cognitive Assessment score between 13-26,
  • Who has the Quick Mild Cognitive Impairment screen score between 48-67,
  • Who has Instrumental Activities of Daily Living Scale score ≥6/8,
  • Who says yes to "Do you have a memory problem?" question,
  • Who can walk independently without using any walking aids
What rules you out
  • Participants who have any musculoskeletal disorders that may cause balance and gait disorders,
  • Who have central or peripheral neurological diseases (eg. stroke, Parkinson's disease or polyneuropathies),
  • Who are using psychiatric drugs that may affect psychiatric disease and/or cognitive performance (Using nonsteroidal anti-inflammatory drugs more than three times a week, which may affect cognitive functions, using...
  • Who has daltonism and
  • Who attends any exercise program last 6 months will not be included in this study.

The study team makes the final eligibility decision.

Where it's taking place

  • Famagusta, Eyalet/Yerleşke, Cyprus

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 50 years to 75 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Famagusta, Eyalet/Yerleşke, Cyprus. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.